St. Josef-Hospital

Futó vizsgálatok

• Még nem toboroz

  A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis

  NCT07873801· 3. fázis· Almirall, S.A.· Forrás

• Toboroz

  A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)

  2025-525009-18-00· 3. fázis· Incyte Corp.· Forrás

• Toboroz

  Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer

  NCT07473128· 3. fázis· Pharmacosmos A/S· Forrás

• Toboroz

  A study to evaluate the efficacy of oxaliplatin- or gemcitabine-based chemotherapy after allocation by standard criteria or by genetic markers in patients with resected pancreatic carcinoma

  NCT05314998· 3. fázis· Universitaetsklinikum Heidelberg AöR· Forrás

• Toboroz

  A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors

  NCT07600476· 1. fázis· Kupando GmbH· Forrás

• Toboroz

  A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  NCT07567001· 3. fázis· Novo Nordisk A/S· Forrás

• Fut, nem toboroz

  A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa

  2025-522440-41-00· 2. fázis· Bluefin Biomedicine Inc.· Forrás

• Toboroz

  A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)

  NCT07282574· 2. fázis· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  A Study of Zasocitinib in Adults With Hidradenitis Suppurativa

  NCT07244263· 2. fázis· Takeda· Forrás

• Toboroz

  Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease

  NCT07378644· 2/3. fázis· Skyhawk Therapeutics, Inc.· Forrás

• Toboroz

  A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa

  NCT07384975· 2. fázis· Navigator Medicines, Inc.· Forrás

• Fut, nem toboroz

  A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

  NCT07170150· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A Study of LAD191 in Adults With Hidradenitis Suppurativa

  NCT07151937· 2. fázis· Almirall, S.A.· Forrás

• Fut, nem toboroz

  A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa

  NCT07287644· 2/3. fázis· Bluefin Biomedicine, Inc.· Forrás

• Fut, nem toboroz

  A Study With CIT-013 in HS Patients

  NCT06993233· 2. fázis· Citryll BV· Forrás

• Fut, nem toboroz

  A study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in participants with moderate to severe hidradenitis suppurativa

  2025-520564-17-00· 3. fázis· MoonLake Immunotherapeutics AG· Forrás

• Fut, nem toboroz

  A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

  NCT07169578· 3. fázis· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)

  NCT06959225· 3. fázis· Incyte Corporation· Forrás

• Fut, nem toboroz

  Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense

  NCT06993610· 2. fázis· Zura Bio Inc· Forrás

• Fut, nem toboroz

  A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis Suppurativa

  NCT06921850· 3. fázis· UCB Biopharma SRL· Forrás

• Toboroz

  Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake

  NCT06571149· 4. fázis· Insel Gruppe AG, University Hospital Bern· Forrás

• Toboroz

  Efficacy and safety study of frexalimab (SAR441344) in adults with relapsing forms of multiple sclerosis

  2023-504358-36-00· 3. fázis· Sanofi-Aventis Recherche & Developpement· Forrás

• Toboroz

  A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisfaction in Participants With Multiple Sclerosis (MS)

  NCT06780150· Hoffmann-La Roche· Forrás

• Toboroz

  KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

  NCT06193889· 2/3. fázis· Kyverna Therapeutics· Forrás

• Fut, nem toboroz

  A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

  NCT06468228· 3. fázis· AbbVie· Forrás

• Toboroz

  Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

  NCT06463587· 3. fázis· Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany· Forrás

• Fut, nem toboroz

  Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis

  NCT06141486· 3. fázis· Sanofi· Forrás

• Leállították

  Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis

  NCT06058156· 2. fázis· Sanofi· Forrás

• Leállították

  A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

  NCT06028230· 2. fázis· Sanofi· Forrás

• Fut, nem toboroz

  A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

  NCT05889182· 3. fázis· AbbVie· Forrás

• Fut, nem toboroz

  HERMES – A research study to look at how ziltivekimab works compared to placebo in people with heart failure and inflammation.

  NCT05636176· 3. fázis· Novo Nordisk A/S· Forrás

• Fut, nem toboroz

  Atezolizumab in Patients With MSI-h/MMR-D Stage II High Risk and Stage III Colorectal Cancer Ineligible for Oxaliplatin

  NCT05118724· 2. fázis· AIO-Studien-gGmbH· Forrás

• Fut, nem toboroz

  A Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep and Atezolizumab

  NCT07280377· 1/2. fázis· Oncolytics Biotech· Forrás

• Fut, nem toboroz

  Adjuvant Nivolumab Treatment in Stage II (IIA, IIB, IIC) High-risk Melanoma

  NCT04309409· 3. fázis· University Hospital, Essen· Forrás

• Fut, nem toboroz

  An open-label extension study evaluating long-term safety, tolerability and effectiveness of ofatumumab in subjects with RMS

  2023-507906-15-00· 3. fázis· Novartis Pharma AG· Forrás

• Fut, nem toboroz

  Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

  NCT02912559· 3. fázis· National Cancer Institute (NCI)· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Hasnyálmirigyrák2 toboroz
• Myasthenia gravis2 toboroz
• Sclerosis multiplex (SM)2 toboroz
• Atópiás dermatitisz (ekcéma)1 toboroz
• Elhízás1 toboroz
• Hidradenitis suppurativa1 toboroz
• Huntington-kór1 toboroz
• Melanóma1 toboroz
• Stroke (szélütés)1 toboroz
• Szívelégtelenség1 toboroz
• Tüdőrák1 toboroz

Lezárt vizsgálatok

• Leállították

  Evaluate Safety and Pharmacokinetics of INF904 in Subjects With Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa

  NCT06555328· 2. fázis· InflaRx GmbH· Forrás

• Lezárult

  A study to evaluate the efficacy and safety of subcutaneous sonelokimab compared with placebo in adult participants with moderate to severe hidradenitis suppurativa

  2024-511363-28-00· 3. fázis· MoonLake Immunotherapeutics AG· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis Suppurativa

  NCT06603077· 2. fázis· Avalo Therapeutics, Inc.· Forrás

• Lezárult

  A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

  NCT06046729· 2. fázis· Eli Lilly and Company· Forrás

• Leállították

  Hidradenitis Suppurativa Study of Izokibep

  NCT05905783· 3. fázis· ACELYRIN Inc.· Forrás

• Lezárult

  A Study to Test the Efficacy and Safety of SAR442970 in Adults With Hidradenitis Suppurativa

  NCT05849922· 2. fázis· Sanofi· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (HS)

  NCT05620836· 3. fázis· Incyte Corporation· Forrás

• Lezárult

  A Study of TAK-341 in Treatment of Multiple System Atrophy

  NCT05526391· 2. fázis· Takeda· Forrás

• Fut, nem toboroz

  IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18)

  NCT05155254· 3. fázis· IO Biotech· Forrás

• Lezárult

  A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF)

  NCT05033080· 3. fázis· Vertex Pharmaceuticals Incorporated· Forrás

• Fut, nem toboroz

  Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)

  NCT04793958· 3. fázis· Mirati Therapeutics Inc.· Forrás

• Lezárult

  A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa

  NCT04901195· 3. fázis· UCB Biopharma SRL· Forrás

• Lezárult

  Open-label Trial in Parkinson's Disease (PD)

  NCT04760769· 3. fázis· AbbVie· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)

  NCT04544436· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS2)

  NCT04396574· 3. fázis· Eli Lilly & Co.· Forrás

• Fut, nem toboroz

  A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)

  NCT04280718· 2. fázis· argenx· Forrás

• Lezárult

  Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS)

  NCT04458051· 3. fázis· Sanofi· Forrás

• Lezárult

  An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to Ofatumumab

  NCT04353492· 3. fázis· Novartis Pharmaceuticals· Forrás

• Lezárult

  Neoadjuvant RCT Versus CT for Patients With Locally Advanced, Potentially Resectable Adenocarcinoma of the GEJ

  NCT04375605· 3. fázis· Universitätsmedizin Mannheim· Forrás

• Lezárult

  A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment

  NCT04083235· 3. fázis· Ipsen· Forrás

• Lezárult

  Patients With ES-SCLC and ECOG PS=2 Receiving Atezolizumab-Carboplatin-Etoposide

  NCT04221529· 2. fázis· AIO-Studien-gGmbH· Forrás

• Lezárult

  Rostock International Parkinson's Disease Study (ROPAD)

  NCT03866603· CENTOGENE GmbH Rostock· Forrás

• Leállították

  Radiotherapy With Pembrolizumab in Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

  NCT03386357· 2. fázis· University of Erlangen-Nürnberg Medical School· Forrás

• Lezárult

  Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy

  NCT01827553· 3. fázis· University of Erlangen-Nürnberg Medical School· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Sclerosis multiplex (SM)45 munka · 8 vizsgálat
• Huntington-kór10 munka · 1 vizsgálat
• Neuromyelitis optica (NMOSD)9 munka · 0 vizsgálat
• Myasthenia gravis7 munka · 2 vizsgálat
• Optic neuritis6 munka · 0 vizsgálat